U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Boston Beer Co. is establishing an R&D center in Canada for non-alcoholic cannabis products.
Dave Burwick, CEO at Boston Beer, the brewer of Samuel Adams beer, said they want to be ready for future opportunities that alcoholic cannabis beverages could present in the US, adding that it could be a new frontier of innovation.
The new division has not yet announced a location, although observers say Canada is a possibility due to its laxer and more uniform cannabis laws than the US.
The new subsidiary will be headed by Paul Weaver, a former director of innovation at Canopy Growth Corp., a major cannabis processor based in Ontario.
Weaver will have the title “head of cannabis.”
